“adenosine-therapeutics” Archives

in
Entry Author Date Location
Novartis Option Fund Managing Director Says First Responsibility is to Portfolio Companies, Dislikes “Corporate VC” Moniker 10/31/08 Boston
A123 Files For “Lucky” IPO, BP Shells out $90M for Verenium’s Biofuel Tech, Alnylam Ventures into New RNA Realm, & More Deals News 08/11/08 Boston
Page 1 of 1